The startup scenario is being changed by bringing in investment and deal activity around AI technologies. The market activity plainly demonstrates that new businesses that had AI as a core product are creating more advanced AI tech-packed away with the heaviest investment from leading VC firms and investors. These investors are putting their stakes vigorously in Conversational AI deep tech startups.

Let's look at some of the recent Conversational AI investments.

Rasa

Conversational Artificial Intelligence startup Rasa Technologies has closed a US$26 million Series B funding round led by Andreessen Horowitz. Reportedly, the recent sum will be invested in improving the company's open-source tools for building chatbots and other AI projects, an area that's undergoing something of a renaissance in the wake of the ongoing COVID-19 health crisis.

Orbita

The Boston-based Orbita raised US$9 million for a conversational AI-powered voice and chatbot platform co-led by Philips Health Technology Ventures and HealthX Ventures along with investors Cultivation Capital and Newark Venture Partners. To note, the company enables a powerful conversational AI platform for healthcare organizations to cost-effectively create and manage HIPAA-compliant virtual healthcare assistants for consumer and clinical applications that increase patient engagement, reduce the cost of care, and improve outcomes.

Bluecore

The marketing technology company, Bluecore recently announced the close of its US$50 million Series D funding round led by existing investor Georgian Partners, who recently raised Canada's first US$1-billion-plus private-sector venture capital fund. Moreover, Bluecore's current investors FirstMark and Norwest also invested in the round. It has been estimated that the new investment will bring the company's total funding to date to more than US$100 million.

Phelix.ai

Phelix.ai, a Canada-based startup that develops automation tools for the health sector, has recently raised a US$1 million seed round. The round was led by Well Health Technologies, which contributed US$250,000. However, other investors were not disclosed. Both the companies also entered into a strategic alliance agreement that grants Well Health Technologies the right to use and sublicense Phelix.ai's clinical assistant automation software.

Omilia

Cyprus headquartered-Omilia that has built a conversational AI for customer support, and has raised US$20 million in its first-ever funding round, having been bootstrapped since 2002. The funding round was backed by Grafton Capital. The money will be used to invest in further growth, after Omilia grew revenue by "more than" 100% in 2019, with the majority of new customers based in the US.